Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -126,726 | -523,901 | -380,636 | -247,012 | -128,642 |
| Depreciation Amortization | 27,665 | 71,281 | 50,752 | 32,128 | 15,398 |
| Income taxes - deferred | N/A | 377 | N/A | N/A | N/A |
| Accounts receivable | -28,372 | -44,991 | -28,625 | -9,420 | -25,010 |
| Other Working Capital | -37,183 | -23,788 | -17,939 | -8,545 | -40,132 |
| Other Operating Activity | 67,212 | 269,690 | 193,956 | 101,547 | 78,229 |
| Operating Cash Flow | $-97,404 | $-251,332 | $-182,492 | $-131,302 | $-100,157 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 130,489 | 304,613 | 212,301 | 121,785 | 50,108 |
| PPE Investments | -9,312 | -28,213 | -19,487 | -13,643 | -5,669 |
| Net Acquisitions | N/A | -57,118 | N/A | -21,838 | N/A |
| Purchase Of Investment | N/A | -100 | -100 | -100 | -100 |
| Purchase Sale Intangibles | -72,134 | N/A | -41,806 | N/A | -14,192 |
| Other Investing Activity | -72,134 | 0 | -41,806 | 0 | -14,192 |
| Investing Cash Flow | $49,043 | $219,182 | $150,908 | $86,204 | $30,147 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,276 | -2,224 | -2,224 | -2,224 | -2,224 |
| Common Stock Issued | 2,444 | 23,101 | 18,747 | 15,771 | 11,755 |
| Financing Cash Flow | $1,168 | $20,877 | $16,523 | $13,547 | $9,531 |
| Exchange Rate Effect | 1,653 | -7,821 | -3,933 | 86 | -1,701 |
| Beginning Cash Position | 197,218 | 216,312 | 216,312 | 216,312 | 216,312 |
| End Cash Position | 151,678 | 197,218 | 197,318 | 184,847 | 154,132 |
| Net Cash Flow | $-45,540 | $-19,094 | $-18,994 | $-31,465 | $-62,180 |
| Free Cash Flow | |||||
| Operating Cash Flow | -97,404 | -251,332 | -182,492 | -131,302 | -100,157 |
| Capital Expenditure | -9,312 | -28,213 | -19,487 | -13,643 | -5,669 |
| Free Cash Flow | -106,716 | -279,545 | -201,979 | -144,945 | -105,826 |